Skip to main content
Premium Trial:

Request an Annual Quote

Abbott's MDx Sales Jump 19 Percent in Q2

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its second-quarter molecular diagnostics sales increased around 19 percent year over year.

The firm posted total molecular diagnostics sales of $105 million for the three-month period ended June 30, compared to $89 million for Q2 2010. Of the $105 million, $45 million of the sales came from the US with the remainder coming from international markets.

The firm reiterated its plans to launch more than 12 new molecular diagnostics products, including oncology and infectious disease assays, over the next few years. It noted that it has submitted for regulatory clearance an ALK gene rearrangement test for non-small cell lung cancer to be used in combination with Pfizer's crizotinib.

Overall, Abbott reported Q2 sales of $9.62 billion, up 9 percent from $8.83 billion for the prior-year second quarter. Its net earnings rose to $1.94 billion, or $1.23 per share, from $1.29 billion, or $.83 per share.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.